Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Publication of GT200400014ApublicationCriticalpatent/GT200400014A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UN METODO PARA TRATAR EL VIRUS DE LA INMUNODEFICIENCIA HUMANA (HIV) QUE COMPRENDE ADMINISTAR UNA CANTIDAD TERAPEUTICAMENTE EFICAZ DE NELFINAVIR EN UNA COMPOSICION FARMACEUTICA, EN EL QUE EL NELFINAVIR SE ADMINISTA CON ALIMENTOS.THE PRESENT INVENTION REFERS TO A METHOD FOR TREATING THE VIRUS OF HUMAN IMMUNODEFICIENCY (HIV) THAT INCLUDES ADMINISTING A THERAPEUTICALLY EFFECTIVE AMOUNT OF NELFINAVIR IN A PHARMACEUTICAL COMPOSITION, IN WHICH NELFINAVIM IS ADMINISTERED.
GT200400014A2003-02-102004-02-10
TREATMENT METHOD WITH NELFINAVIR
GT200400014A
(en)
ORAL DOSING UNIT INCLUDING AN ANTAGONIST AGENT FOR PUMPS OF PROTONS AND EXCIPIENTS OF BASIC CHARACTER; PROCEDURE FOR PREPARATION, USEFUL TO TREAT DISEASES CAUSED BY AN INCREASED SECRETION OF GASTRIC ACIDS.